Real-world experiences: Efficacy and tolerability of pirfenidone in clinical practice - Fang, Chuling; Huang, Hui; Guo, Jian; Ferianc, Martin; Xu, Zuojun (PloS one, 2020)
Keywords: Aged; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Biology and Life Sciences; Biopsy; Body mass; Body Mass Index; Body size; Carbon monoxide; Carbon Monoxide - chemistry; Care and treatment; CAT scans; China; Clinical medicine; Clinical trials; Computed tomography; Connective tissue diseases; Connective tissues; Development and progression; Diffusion rate; Diseases; Drug dosages; Female; Fibrosis; Hospitals; Humans; Idiopathic Pulmonary Fibrosis - classification; Idiopathic Pulmonary Fibrosis - diagnostic imaging; Idiopathic Pulmonary Fibrosis - drug therapy; Indexing; Lung diseases; Male; Medical prognosis; Medical research; Medical schools; Medicine; Medicine and Health Sciences; Middle Aged; Nintedanib; Patients; Physical Sciences; Pirfenidone; Pulmonary fibrosis; Pyridones - administration & dosage; Pyridones - adverse effects; Research and Analysis Methods; Respiratory tract diseases; Retirement benefits; Retrospective Studies; Safety; Skin; Statistical analysis; Supervision; Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor necrosis factor-TNF; Vital Capacity; Work experience; China; Beijing China